Phase II Study of Regorafenib in Metastatic Soft Tissue Sarcoma

NCT01900743 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

219

Enrollment

OTHER

Sponsor class

Conditions

Sarcoma

Interventions

DRUG: Regorafenib
DRUG: Placebo

Sponsor

Centre Oscar Lambret

Collaborators

[object Object]